News

Industry news focusing on the people and organizations who work in the clinical trials profession.

There is currently no set of standards for how individuals acquire the ability to perform satisfactorily and demonstrate the required levels of competence.

The primary objectives of GCP are to protect the safety, rights, and welfare of subjects, and to ensure the credibility of trial data and resulting reports.

Increasing global competition from generics and a glut of expiring patents have forced many biopharmaceutical and medical device companies to rethink their operational strategies.

The Drug Information Association (DIA) is preparing to celebrate 25 years of training and education provision at its annual EuroMeeting.

The end of the highly acrimonious election campaign has signaled a shift by policy-makers and interest groups to focus on dealing with the so-called government "fiscal cliff."

The rocky economy continues to wreak havoc on employment and drug development.